Conoce los detalles de la Brigada Internacional '65 Años de Amor por Cuba' y su agenda de actividades en La Habana.

LA HABANA, Cuba.- La Coordinadora Ecuatoriana de Amistad y Solidaridad con Cuba (CEASC) y la Asociación Ecuatoriana de Amistad con el Pueblo Saharaui (AEAPS) participaron en una amplia agenda de actividades que cumplió la Brigada Internacional “65 Años de Amor por Cuba”, entre el 22 de diciembre del 2025 y el 02 de enero del 2026, en La Habana, Caimito y la Ciénega de Zapata, con ocasión del aniversario 65 de fundación del Instituto Cubano de Amistad con los Pueblos (ICAP).

Wishing all people worldwide happy holidays and a healthy new year.

El presidente de la República, Miguel Díaz-Canel Bermúdez, primer secretario del Comité Central del Partido Comunista de Cuba, asistió en la tarde de este lunes al acto central por el aniversario 65 d...

¿Sabías que Tijuana contó con un helicóptero llamado Pegaso? 🚁 Pertenecía a la SSPC de Tijuana y brindaba patrullaje aéreo como parte de las estrategias de seguridad. Por allá, entre 2001 y 2004, incluso nos visitó en ICAP, dejando huella en una etapa clave de la seguridad en la ciudad. #MemoriaUrbana #Tijuana #HistoriaDeLaSeguridad #Pegaso

On Tuesday, December 16, 2025, ICAP presented the Grand Rounds — Doxycycline post-exposure prophylaxis for bacterial STIs and its impact on antimicrobial resistance. Doxycycline post-exposure prophylaxis (Doxy PEP) is a new tool to prevent sexually transmitted infections (STIs). This talk by Jean-Michel Molina, MD, PhD, professor of Medicine at the University of Paris Cité and head of the Infectious Diseases Department at the Saint-Louis and Lariboisière Hospitals in Paris, covered the evidence supporting the use of DoxyPEP to prevent syphilis and chlamydia infection in men who have sex with men and transgender women exposed to a high risk of STIs.The effect of DoxyPEP on gonorrhea and M. genitalium infections was also addressed as well as its impact on antimicrobial resistance (AMR) for both pathogens and other bystander bacteria. Data on women was also presented. Jean-Michel Molina, MD, PhD, is professor of Medicine at the University of Paris Cité and head of the Infectious Diseases Department at the Saint-Louis and Lariboisière Hospitals in Paris. He has been involved in studies assessing new drugs and strategies for the treatment of HIV and has chaired the ANRS clinical trial group for the past 12 years. His department follows a cohort of more than 6,000 people living with HIV. He is also member of the INSERM research team U1342 investigating cell biology of viral infections at the Saint-Louis research institute. Since 2018, he has been involved in the prevention of HIV and STIs and led the ANRS IPERGAY PrEP trial in men who have sex with men, with his unit following more than 4,000 people on PrEP. Professor Molina has recently taken a new position as medical director of the Pasteur Institute in Paris with the task of fostering translational and clinical research in infectious diseases.

Hekim Birliği Hukuk Birimi, Van Yüzüncü Yıl Üniversitesi Tıp Fakültesi’nde görev yapan sendika üyesi öğretim üyesi hekimler için icap nöbeti ücreti ödenmesi talebiyle yaptıkları başvurunun idarece red...

Η Kinsen βραβεύθηκε από την ICAP CRIF ως True Leader ανάμεσα σε 114 εταιρείες-ηγέτες που ορίζουν το μέλλον της ελληνικής οικονομίας.

Η ΧΗΤΟΣ, μέλος του Ομίλου Green Beverages, συγκαταλέγεται ανάμεσα στις κορυφαίες εταιρίες της χώρας, κατακτώντας τη διάκριση True Leader 2024, στο πλαίσιο του θεσμού επιχειρηματικής αριστείας της ICAP CRIF.

Refugee populations in Uganda had comparable HIV care cascade outcomes to the general population. Although HIV prevalence differed substantially, both groups showed similar progress towards treatment ...

Vivacom получи престижно отличие в категорията „Устойчиви компании“ в рамките на годишните награди True Leaders на ICAP CRIF България. Признанието се връчва на компании, оценени с високи резултати за устойчиво развитие. Отличието е още едно потвърждение, че Vivacom интегрира устойчиви практики в стратегическите си решения и така формира посоката, в която телекомът да се развива. „Това е второто поредно отличие за Vivacom в рамките на седмица за устойчиво развитие, което още веднъж потвърждава, че усилията на компанията се разпознават и ценят.